KLR

Kailera Therapeutics Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Kailera Therapeutics holds $624.8M in total assets. Shareholders' equity is -$432.1M against $10.5M in total debt. Cash and equivalents total $111.8M. The current ratio is 9.67 and debt-to-equity is -0.024.

Market Cap$2.8B